PROFOUND MEDICAL CORP. Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax
PROFOUND MEDICAL CORP. (PROF) reported Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax of -$950.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax · last filed 2026-08-06
- PROFOUND MEDICAL CORP. other comprehensive income (loss), foreign currency transaction and translation adjustment, net of tax for the quarter ending 2026-06-30 was -$950.00K, a 135.02% decline year-over-year.
- PROFOUND MEDICAL CORP. other comprehensive income (loss), foreign currency transaction and translation adjustment, net of tax for the quarter ending 2026-03-31 was -$1.00M, a 1075.73% decline year-over-year.
- PROFOUND MEDICAL CORP. other comprehensive income (loss), foreign currency transaction and translation adjustment, net of tax for the quarter ending 2025-12-31 was $275.00K.
- PROFOUND MEDICAL CORP. other comprehensive income (loss), foreign currency transaction and translation adjustment, net of tax for the quarter ending 2025-09-30 was -$808.00K, a 238.36% decline year-over-year.
- PROFOUND MEDICAL CORP. other comprehensive income (loss), foreign currency transaction and translation adjustment, net of tax for fiscal 2025 was $2.28M.
- PROFOUND MEDICAL CORP. other comprehensive income (loss), foreign currency transaction and translation adjustment, net of tax for fiscal 2024 was -$2.82M, a 538.35% decline from fiscal 2023.
- PROFOUND MEDICAL CORP. other comprehensive income (loss), foreign currency transaction and translation adjustment, net of tax for fiscal 2023 was $644.00K.
| Period end | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax 3 month | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax 6 month | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax 9 month | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$950.00K 10-Q · filed 2026-08-06 | -$1.96M 10-Q · filed 2026-08-06 | -$1.68M derived: sum of 3 quarters · filed 2026-08-06 | -$2.49M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$1.00M 10-Q · filed 2026-08-06 | -$730.00K derived: sum of 2 quarters · filed 2026-08-06 | -$1.54M derived: sum of 3 quarters · filed 2026-08-06 | $1.18M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $275.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$533.00K derived: sum of 2 quarters · filed 2026-03-05 | $2.18M derived: sum of 3 quarters · filed 2026-08-06 | $2.28M 10-K · filed 2026-03-05 |
| 2025-09-30 | -$808.00K 10-Q · filed 2025-11-13 | $1.91M derived: sum of 2 quarters · filed 2026-08-06 | $2.01M 10-Q · filed 2025-11-13 | $40.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $2.71M 10-Q · filed 2026-08-06 | $2.82M 10-Q · filed 2026-08-06 | $848.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.43M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $103.00K 10-Q · filed 2026-08-06 | -$1.86M derived: sum of 2 quarters · filed 2026-08-06 | -$1.28M derived: sum of 3 quarters · filed 2026-08-06 | -$1.75M derived: sum of 4 quarters · filed 2026-08-06 |
| 2024-12-31 | -$1.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$1.38M derived: sum of 2 quarters · filed 2026-03-05 | -$1.85M derived: sum of 3 quarters · filed 2026-03-05 | -$2.82M 10-K · filed 2026-03-05 |
| 2024-09-30 | $584.00K 10-Q · filed 2025-11-13 | $114.00K derived: sum of 2 quarters · filed 2025-11-13 | -$855.00K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | -$470.00K 10-Q · filed 2025-11-13 | -$1.44M 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | -$969.00K 10-Q · filed 2025-11-13 | |||
| 2023-12-31 | $644.00K 10-K · filed 2025-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |